Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 56.71% | -46.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 56.71% | -46.00% | |||
| Cost of Revenue | 23.02% | -50.33% | |||
| Gross Profit | 127.98% | -33.78% | |||
| SG&A Expenses | 8.73% | 35.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.20% | 4.08% | |||
| Operating Income | -7.77% | -9.38% | |||
| Income Before Tax | -10.84% | -7.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.84% | -7.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.84% | -7.67% | |||
| EBIT | -7.77% | -9.38% | |||
| EBITDA | -7.73% | -9.25% | |||
| EPS Basic | -10.18% | -7.16% | |||
| Normalized Basic EPS | -10.07% | -7.20% | |||
| EPS Diluted | -8.25% | -9.07% | |||
| Normalized Diluted EPS | -10.07% | -7.20% | |||
| Average Basic Shares Outstanding | 0.63% | 0.50% | |||
| Average Diluted Shares Outstanding | 0.63% | 0.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||